相关实验视频

Updated: Jul 1, 2025

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

一种基于CRISPR/Cas9基因编辑技术的病毒样粒子候选疫苗,可以引起对SARS-CoV-2的广泛保护

Weiqi Wang¹, Shen Wang², Xianyong Meng³

¹College of Veterinary Medicine, Jilin University, Changchun, 130062, Jilin, China; Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, 130122, Jilin, China.

Antiviral research

|March 6, 2024

概括

一种新的天花病毒载体疫苗 (ALVAC-VLPs) 有效地预防SARS-CoV-2变种. 这种广泛的COVID-19疫苗引发了强大的T和B细胞反应,为新兴菌株提供了希望.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
疫苗学疫苗学疫苗学

背景情况:

严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 变种对现有的COVID-19疫苗疗效构成重大威胁.
需要广泛的疫苗和对抗SARS-CoV-2的免疫反应的更深入的理解.

研究的目的:

开发和评估一种新的SARS-CoV-2病毒样颗粒 (VLPs) 疫苗,该疫苗基于天花病毒载体 (ALVAC-VLPs).
调查潜在的免疫机制,从而提供对SARS-CoV-2及其变种的保护.

主要方法:

使用CRISPR/Cas9技术开发ALVAC-VLPs疫苗.使用CRISPR/Cas9技术开发ALVAC-VLPs疫苗.使用CRISPR/Cas9技术开发ALVAC-VLPs疫苗.
在小鼠和黄金仓鼠中进行的免疫研究挑战了SARS-CoV-2 (野生型和变种).
免疫反应的分析,包括T和B细胞激活,以及涉及收费类受体4 (TLR4) 的机制研究.

主要成果:

艾尔瓦克-VLPs免疫在小鼠中诱导了特定的T和B细胞反应,赋予了对致命的SARS-CoV-2挑战的抵抗力.
用ALVAC-VLP接种疫苗的黄金仓鼠对野生型和多种SARS-CoV-2变种 (Beta,Delta,Omicron BA.1,BA.2) 显示出保护,由减少疾病严重程度和病毒载荷证明.
疫苗的有效性与TLR4介导的树突细胞的招募有关,促进T卵泡辅助细胞 (Tfh) 的分化,生殖中心 (GC) B细胞的增殖和血细胞的产生.

结论:

开发的ALVAC-VLPs疫苗显示出显著的免疫性和针对SARS-CoV-2及其变体的广泛疗效.
这些发现突显了ALVAC-VLP作为COVID-19安全有效的疫苗策略的潜力.
了解TLR4依赖性免疫通路为未来的疫苗开发提供了宝贵的见解.

关键词:

这就是CRISPR/Cas9的作用.雀病毒的载体病毒载体.细胞免疫力细胞免疫力交叉中和抗体的抗体.收费类受体4 收费类受体4 病毒样粒子疫苗病毒样粒子疫苗

更多相关视频

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"

Published on: March 31, 2021

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...